Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies
2019 ◽
Vol 105
(2)
◽
pp. 468-477
◽
Maria-Victoria Mateos
◽
Andrew Spencer
◽
Ajay K. Nooka
◽
Ludek Pour
◽
Katja Weisel
◽
...
2019 ◽
Vol 19
(10)
◽
pp. e266
Thierry Facon
◽
Ruben Niesvizky
◽
Katja Weisel
◽
Sara Bringhen
◽
P. Joy Ho
◽
...
Thierry Facon
◽
Ruben Niesvizky
◽
Katja Weisel
◽
Sara Bringhen
◽
P. Joy Ho
◽
...
2020 ◽
Vol 42
◽
pp. 253-254
H. Quach
◽
A. Nooka
◽
O. Samoylova
◽
C.P. Venner
◽
T. Facon
◽
...
2018 ◽
Vol 36
(2)
◽
pp. 463-470
◽
Maria-Victoria Mateos
◽
Hartmut Goldschmidt
◽
Jesus San-Miguel
◽
Joseph Mikhael
◽
Lucy DeCosta
◽
...
Hang Quach
◽
Ajay Nooka
◽
Olga Samoylova
◽
Christopher Venner
◽
Kihyun Kim
◽
...
Kenshi Suzuki
◽
Chang-Ki Min
◽
Kihyun Kim
◽
Je-Jung Lee
◽
Hirohiko Shibayama
◽
...
2019 ◽
Vol 3
(S1)
◽
pp. 966-967
K. Matsue
◽
K. Sunami
◽
K. Suzuki
◽
N. Takezako
◽
A. Shinagawa
◽
...
Shigeki Ito
◽
Maki Asahi
◽
Tadashi Shimoyama
◽
Yuzo Suzuki
◽
Ryousei Sasaki
◽
...
2019 ◽
Vol 3
(S1)
◽
pp. 635-636
T. Facon
◽
R. Niesvizky
◽
K. Weisel
◽
S. Bringhen
◽
P.J. Ho
◽
...
Meletios A. Dimopoulos
◽
Ruben Niesvizky
◽
Katja Weisel
◽
David S. Siegel
◽
Roman Hajek
◽
...
Close
Export Citation Format
Close
Share Document
Close